Publication
Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06-24 trial.
Felipe Couñago, Carmen González, Alfonso Gómez-Iturriaga, Ana Álvarez, Marina Santos, Ana Boladeras, Nagore García, Sandra Fernández, Sandra Guardado, Abrahams Ocanto, Daniela Gonsalves, Luis Glaría, Ana Castaño, Patricia Martín, Laura Montezuma, Arantxa Mera, Joel Mases, Gerard Meca, Víctor Duque-Santana, Jesús Olivera, Sara Pérez, Ivan Henriquez, Bárbara Malavé, Aurora Rodríguez, Rafael García, David Büchser, Josep Garre, Manuel Altabas, Jeannette Valero, Raquel García-Gómez, Miguel Berenguer, Ángel Calvo, Rafael Ordoñez, Patricia Willisch, Aldara Candal, Neus Aymar, Esther Mayrata, Fernando López-Campos
- Source
- PubMed
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260929-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND AND PURPOSE: Moderate hypofractionation is increasingly used in salvage radiotherapy (SRT) after radical prostatectomy, although prospective data in the postoperative setting remain limited. We evaluated early adverse events and patient-reported outcomes (PROs) according to fractionation…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 1
- trialNCT05781217registry_reference1.00
Registered trialsNCT05781217
Curated evidence
Evidence citing this paper (0)
Data not yet available